Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Comment by BioTeckon Nov 02, 2022 9:56pm
222 Views
Post# 35068573

RE:RE:Global news this morning

RE:RE:Global news this morningDepending on cost, it could be a good alternative for newly diagnosed patients. If it's only one injection, it'd render the pouch useless in about 80 years time. If you need continuous injections, you're just replacing insulin with another drug. I'm not too worried about this impacting the short term price of sernova but just goes to show the longer you wait, the closer the competition gets. Yes I know there would need to be trials etc for years but any big pharma would easily buy them rather than the pouch as it fits their existing sales model. No one is going to pay top dollar for the pouch for a couple years advantage if there are easier solutions in the pipeline. Remember drug companies are in it for the money, cures don't make as much as treatments. Just my two cents. Oh and spill is a clown. I figure a post wouldn't be complete without some spillup bashing. He is really earning his name lately.
LastHurrah wrote: Finished the first human trial - two are insulin free. They are looking for another 40 type 1 patients - the news clip this morning isn't available for posting yet (hence the 2021 post). The caveat is that the patients have to be "newly diagnosed" suggesting that it doesn't work for existing longer term Type 1 patients. Treated with a crones drug.


<< Previous
Bullboard Posts
Next >>